Disclosure 0001395064-26-000340-1

SEC FORM 4

$640,278.90

TAKEDA PHARMACEUTICAL CO LTD (TAK)

Sale of 34,535 shares at $18.54 per share.

Reporting Person Duprey Lauren Rusckowski · Officer Title Chief Transformation Officer · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001395064-26-000340 · filed 2026-09-15 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "TAKEDA PHARMACEUTICAL CO LTD (TAK)." Disclosed 2026-09-15. https://desqlong.com/cards/0001395064-26-000340-1 (retrieved 2026-09-26).